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Fish immunology research is at a pivotal point with the increasing availability of functional
immunoassays and major advances in omics approaches. However, studies on fish
B cells and their distinct subsets remain a challenge due to the limited availability of
differentially expressed surfacemarkers. To address this constraint, cell surface proteome
of Atlantic salmon IgM+ B cells were analyzed by mass spectrometry and compared
to surface proteins detected from two adherent salmon head kidney cell lines, ASK
and SSP-9. Out of 21 cluster of differentiation (CD) molecules identified on salmon
IgM+ B cells, CD22 and CD79A were shortlisted as potential markers based on the
reported B cell-specific surface expression of their mammalian homologs. Subsequent
RT-qPCR analyses of flow cytometry-sorted subpopulations from head kidney leukocytes
confirmed that both cd22 and cd79a genes were highly expressed in IgM+ lymphoid cells
but were observed in barely detectable levels in IgM− non-lymphoid suspension and
adherent cells. Similarly, significantly high cd22 and cd79a mRNA levels were observed
in IgM+ or IgT+ lymphoid cells from the spleen and peritoneal cavity, but not in their
corresponding IgM− IgT− non-lymphoid fractions. This suggests that the B cell restrictive
expression of CD22 and CD79A extend down to the transcription level, which was
consistent across different lymphoid compartments and immunoglobulin isotypes, thus
strongly supporting the potential of CD22 and CD79A as pan-B cell markers for salmon.
In addition, this study provides novel information on the salmon B cell surface protein
repertoire, as well as insights on B cell evolution. Further investigation of the identified
salmon CD molecules, including development of immunological tools for detection, will
help advance our understanding of the dynamics of salmon B cell responses such as
during infection, vaccination, or immunostimulation.
Keywords: B cells, cell surface markers, teleost fish, salmon, CD22, CD79A, IgM, proteomics
Peñaranda et al. Salmon B Cell Marker
INTRODUCTION
The sustainability of aquaculture is constantly being
challenged by the occurrence and re-occurrence of infectious
diseases (1). Fish vaccination has become the main prophylactic
strategy against these economically-devastating pathogens.
However, unlike many bacterial vaccines that are highly
protective, most of the available vaccines against viral pathogens
in salmon only provide suboptimal protection (2). It is not clear
why the elicited immune responses of fish virus vaccines are not
efficient in providing protection against subsequent infection.
Consequently, an important question is: What set of host
responses constitute protective immunity in salmon? Critical
to this host response are the B cells with diverse functional
properties that encompass both the innate and adaptive arms
of the immune system, including antigen presentation (3),
phagocytosis (4), production of natural (5) and antigen-specific
antibodies (Abs) (6, 7), and the generation of immunological
memory [reviewed in (8)].
Different lineages and subsets of B cells exist, each exhibiting
specific phenotypic characteristics that respond differentially to
TLR ligands, pathogens, and/or immunogens. In mammals, four
subsets that belong either to the B-1 or B-2 lineages have been
clearly defined. B-2 cells consist of two subpopulations: the more
conventional follicular (FO) B cells that constitute the major
subset in the spleen and trigger the formation of germinal centers
and the subsequent production of plasmablasts, plasma cells,
and memory B cells with high affinity Ag-binding capacities
upon activation of T cell dependent (TD) antigens [reviewed in
(9)]; and the marginal zone (MZ) B cells that integrate classical
innate and adaptive signaling pathways to mount rapid antibody
responses, particularly to blood-borne pathogens [reviewed in
(10)]. Similar to MZ B cells, B-1 cells, which can be subdivided
further into B1a and B1b based on their CD5 surface expression,
have important innate functions such as phagocytosis and
production of polyreactive natural Abs in a T cell independent
(TI) manner (11, 12). The B-1 cells are predominantly located in
the peritoneal cavity (13), but are also present in the spleen and
other lymphoid organs at very low levels. While initially thought
to lack memory B cell generation, recent data have shown that
these innate-like B cells also generate memory B cells during TI
immune responses [reviewed in (14–16)].
As the first vertebrate group that possesses all elements of
adaptive immunity, teleost fish are able to execute immune
functions comparable to that of mammals. Although clear
differences exist between the structure and organization of the
teleost and mammalian immune systems, functional equivalent
lymphoid compartments have been reported [reviewed in (17,
18)]. Analogous to the mammalian bone marrow (BM), the
teleost head kidney (HK) serves as both the major hematopoietic
tissue and reservoir for long-lived plasma cells (6). In the absence
of lymph nodes, teleost spleen constitutes as the main secondary
lymphoid organ, where the majority of naïve B cells mature and
circulate for continuous immune surveillance. In addition to
the systemic lymphoid compartments, teleost peritoneal cavity
also houses B cells whose development and migration pathways
remain largely unexplored (19). In contrast to mammals,
however, teleosts lack follicular structures and do not form
distinguishable germinal centers (20). Little is still also known
about the characteristics of teleost memory B cells but it appears
to have a relatively low proliferation potential (6). Moreover,
their systemic Ab responses rely on unswitched low-affinity IgM
responses (21).
Three classes of immunoglobulins (Igs) have been identified
in teleosts: IgM, IgD, and IgT (or IgZ in some species), with
IgM+ being the predominant surface Ig isotype (22). IgD is
usually co-expressed on the surface of teleost IgM+ B cells,
although single positive IgM+ or IgD+ B cells (23) also exist.
IgT+ only B cells comprise a separate lineage of fish B cells
that appears to have a main role in mucosal immunity (24).
Morphological and functional studies suggest that teleost B cells
resemble mammalian B1 cells more than B2 cells (25, 26).
In fact, it is hypothesized that mammalian innate-like B cells,
characterized by high surface IgM expression (27), evolved from
fish IgM+ B cells (18), with the B2 lineage emerging later
as a more efficient subset that gradually acquired a dominant
role in the mammalian adaptive immunity. Fish B cells exhibit
both innate and adaptive immune functions (6), but whether
these functions are performed by distinct B cell subsets or not
is unknown. Specifically, which B cell subpopulation/s and/or
lineages play an important role in protection against infection
and/or immunity following vaccination are still open questions
in fish immunology.
Cluster of differentiation (CD) is a system used for identifying
cell surface markers for various leukocyte subpopulations,
including B cells. At present, at least 371CD proteins have
been reported in mammals (28)—making immunophenotyping
a rather trivial task. In contrast to the mammalian system
where different lineages and subtypes of B cells can be identified
and sorted with greater clarity through commercially available
marker Abs, studying the dynamics of fish B cell responses
has been challenging due to lack of pan and subset-specific
markers. For Atlantic salmon, in particular, B cells are currently
sorted from the total leukocyte population using surface Igs
as sole markers, typically via the predominant IgM isotype
(22, 29). While this approach has been extremely useful,
the binding of Abs to surface Igs could trigger unwanted
activation of the BCR, which may interfere with downstream
assays. In addition, since the status of surface Ig expression
of salmon B cells at various stages of differentiation (i.e.,
putative naïve B cells, plasmablasts, plasma cells, or memory
B cells) is largely unknown, some of these subsets may not be
detected during sorting and hence, will be excluded from further
analysis.
To address this current limitation, we aimed to identify
CD molecules than can be potentially used as pan- or subset-
specific B cell markers and, in turn, facilitate molecular,
and functional investigations of the heterogeneous salmon
B cell population. Additionally, we aimed to profile the
salmon B cell surface proteome in order to have a better
understanding of the phenotypic characteristics of teleost IgM+
B cells.
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MATERIALS AND METHODS
Experimental Fish
Healthy Atlantic salmon (Salmo salar L.) QTL fish strain
Aquagen standard (Aquagen, Kyrksæterøra, Norway) were
obtained from the Tromsø Aquaculture Research Station
(Tromsø, Norway). Fish were kept at 10◦C in tanks supplied
with running filtered water, natural light and fed on commercial
dry feeds (Skretting, Stavanger, Norway). Estimated weight
of fish used for isolation of peripheral blood leukocytes
(PBL) and subsequent sorting of IgM+ B cells for proteomics
analyses was 700–900 g. Head kidney leukocytes (HKL) were
collected separately from the same batch of fish. Peritoneal
cavity leukocytes (PeL) and splenocytes (SpL) were collected
simultaneously from another batch of smaller fish (estimated
mean weight:∼60 g).
Cell Culture
Atlantic Salmon Kidney (ASK) cells (30) and Salmo salar
pronephros 9 (SSP-9) cells (31), derived from the major
hematopietic tissue of Atlantic salmon, were grown as
monolayers at 20◦C in Leibovitz (L-15) medium (Gibco,
Life Technologies). ASK cell culture medium was supplemented
with P/S (100 units/mL penicillin, 100µg/mL streptomycin)
and 12% fetal bovine serum (FBS), while SSP-9 cell culture
medium was supplemented with 50µg/mL gentamycin and
8% FBS. Five T-75 flasks were seeded with ASK or SSP-9 cells
at a density of ∼2 × 106 cells per flask and collected after
72 h at 90% confluence for subsequent cell surface protein
isolation.
Tissue Collection and Leukocyte Isolation
Blood was extracted from the caudal vein of Atlantic salmon
using a vacutainer with 68 I.U. sodium heparin (Becton
Dickinson) and immediately transferred into transport medium
(L-15 with P/S, 2% FBS, and 20 IE/mL heparin). Spleen and HK
were aseptically collected into transport medium after ensuring
that all blood was drained from fish tissues. Cells from salmon
peritoneal cavity were obtained by lavage and immediately stored
in transport medium.
Leukocyte isolations (PBL, HKL, SpL, or PeL) were performed
on Percoll gradients as described previously (32). Blood
suspension was placed directly onto 54% Percoll (GE Healthcare)
and centrifuged at 400 × g for 40min at 4◦C. Spleen and HK
were homogenized on 100-µm cell strainers (Falcon), loaded
onto 25/54% discontinuous Percoll gradients, and centrifuged as
above. Similarly, peritoneal cavity cells were loaded onto 25/54%
discontinuous Percoll gradient for PeL isolation. Leukocytes at
the interface were collected and washed twice in L-15 with P/S
before further use.
For stimulation with lipopolysaccharide (LPS), freshly isolated
PBLs were seeded in two T25 flasks (Nunclon Delta Surface
ThermoFisher Scientific, 6.25 × 106 cells/flask). One flask was
treated with 50µg/mL LPS (purified by Phenol extraction from
Escherichia coli O111:B4, Sigma-Aldrich) diluted in Dulbecco’s
Phosphate Buffered Saline (DPBS; Sigma-Aldrich), while control
group received only DPBS. Cells were incubated at 14◦C for 72 h
before staining, sorting, and surface protein isolation as detailed
below.
Cell Staining and FACS Sorting
Total leukocytes were centrifuged at 500 × g, resuspended
in PBS+ (Dulbecco PBS with 1% BSA, filter-sterilized), and
stained with anti-salmon IgM (IgF1-18) (1:200 dilution) and/or
anti-trout IgT (2µg/mL) monoclonal antibodies (mAbs) for
30min. These mAbs were generously provided by Dr. Karsten
Skjødt and Prof. Oriol Sunyer, respectively. Salmon anti-IgM
have been shown to recognize both IgM-A and -B isotypes of
Atlantic salmon (29), while trout α-IgT has been previously
validated for cross-specificity with Atlantic salmon IgT (22).
After two washing steps, leukocytes were incubated with isotype
specific secondary Abs: IgG1-RPE (1:400 dilution) and IgG2a-
APC (1:400 dilution), respectively, and viability dye FVD780
(1 µL/mL; eBioscience) in PBS+ for 20min. All staining and
centrifugation steps were done at 4◦C.
Stained leukocytes were resuspended in PBS+ at 5.0 × 107
cells/mL for sorting using the BD FACS Aria III flow cytometer
(BD Biosciences). Dead cells (FVD780+) and doublets (SSC-
A vs. SSC-H) were excluded from the population. Remaining
cells were sorted on the basis of their forward scatter (FSC)
and side scatter (SSC) profiles, and then on their IgM+ (RPE
fluorescence emission) and/or IgT+ (APC fluorescence emission)
surface expression. FSClow SSClow subpopulation that excludes
granulocytes and myeloid cells was designated lymphoid gate.
Cells outside this gate were considered “non-lymphoid” (nL).
PBLs with surface IgM expression within the lymphoid gate (PBL
L IgM+, Figure 1A) were collected in cell culture media and
used as samples for surface protein isolation by biotinylation
enrichment method.
For the validation of B-cell restrictive expression of candidate
pan-B cell markers at the mRNA level, sorted HKL, SpL, and
PeL subpopulations were used for RT-qPCR assays. Leukocytes
were collected in culture either as suspension (SC) and adherent
(AC) cells and stained separately as described above, and then
sorted by FACS based on their FSC/SSC gating profile: lymphoid
(L) vs. non-lymphoid (cells outside the lymphoid gating, nL)
and their IgM and/or IgT surface expression (IgM+ vs. IgM−,
IgT+ vs. IgT−). For HKLs, 4 subpopulations were obtained:
SC within the lymphoid gate that was either IgM+ (HKL SC-
L IgM+) or IgM− (HKL SC-L IgM−); non-lymphoid SC that
was IgM− (HKL SC-nL IgM−); and non-lymphoid AC that
was IgM− (HKL AC-nL IgM−) (Figure 2A). SpLs, which were
mostly suspension cells, were sorted as lymphoid cells with
either IgM+ (SpL L IgM+); IgT+ (SpL L IgT+), or IgM−IgT−
(SpL L IgM−IgT−) surface expression; and non-lymphoid cells
without IgM and IgT surface expression (SpL nL IgM−IgT−)
(Figure 3A). Finally, suspension cells from PeLs were sorted as
lymphoid cells expressing either IgM (PeL L IgM+) or IgT (PeL
L IgT+) on their surface; and non-lymphoid cells without IgM
and IgT surface expression (PeL nL IgM−IgT−) (Figure 4A).
These HKL, SpL, and PeL subsets were sorted directly on
RNAProtect Cell Reagent (Qiagen) and stored at −80◦C until
RNA extraction.
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FIGURE 1 | Isolation and identification of CD molecules on surface of Atlantic salmon B cells and head kidney cell lines. (A) Schematic diagram of proteomics
workflow performed in the study. (B) Venn diagram comparing the CD molecules detected on cell surface of sorted IgM+ PBLs vs. head kidney cell lines, ASK and
SSP-9, of Atlantic salmon.
Cell Surface Protein Isolation
Cell surface proteins from Atlantic salmon cell lines and IgM+
PBLs were isolated using the Pierce R© Cell Surface Protein
Isolation Kit (Thermo Scientific) according to the manufacturer’s
protocol. ASK and SSP-9 monolayers (∼4 × 107 cells) were
quickly washed twice with ice-cold phosphate buffered saline
(PBS) followed by incubation with 0.25 mg/mL Sulfo-NHS-
SS-Biotin in ice-cold PBS (10mL biotin solution per flask)
on a rocking platform (100 rpm) for 30min at 4◦C. The
biotinylation reaction was quenched by adding 500 µL of the
provided Quenching Solution. Cells were harvested by gentle
scraping, pooled, rinsed with Tris Buffered Saline (TBS), and
lysed using the provided Lysis Buffer with Protease Inhibitor
Cocktail (HaltTM ThermoFisher Scientific). Cells were sonicated
on ice at low power using five 1 s bursts and then incubated
for 30min on ice with intermittent vortexing. The lysates were
centrifuged at 10,000 × g for 2min at 4◦C to remove cell
remnants and the resulting clarified supernatant was added to
500µL of NeutrAvidin Agarose slurry. Biotinylated proteins were
allowed to bind to the NeutrAvidin by incubating for 1 h at
room temperature (RT) in the closed column with end-over-end
mixing on an orbital rotator. Unbound proteins were removed
by centrifugation of the column at 1,000 × g for 1min followed
by repetitive washing using the provided Wash Buffer with
protease inhibitor. Finally, the captured surface proteins were
eluted from the biotin-NeutrAvidin Agarose by incubation with
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FIGURE 2 | Restrictive gene expression of candidate pan-B cell markers in leukocytes from head kidney, a primary lymphoid organ of salmon. Suspension and
adherent head kidney leukocytes (HKLs) were collected separately after 72 h in culture and subsequently sorted by flow cytometry based on cell size and granularity
(FSC vs. SSC) and then surface IgM expression. Representative dot plot of the HKL subpopulations are shown in (A) with mean percentage of each fraction indicated
in the graph. To ensure purity and quality of the sorted HKL subpopulations, expression of several marker genes: igd (B cell subset), mcsfr (macrophage), cd3-z2 (T
cells), and cd9 (broad expression) were examined by RT-qPCR assay (B). Upon validation of sorting protocol, gene expression of cd22 and cd79a genes were
subsequently determined (C). Each bar represents mean relative expression data from 3 to 4 fish ± SEM. Means with different letters are significantly different
(two-tailed t-test with Welch’s correction, p < 0.05).
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FIGURE 3 | Restrictive gene expression of candidate pan-B cell markers in leukocytes from spleen, a secondary lymphoid organ of salmon. Freshly isolated
splenocytes were sorted based on size and granularity (FSC vs. SSC) and then surface expression of IgM or IgT. Representative dot plot of the SpL subpopulations
are shown in (A) with mean percentage of each fraction indicated in the graph. Cells within the lymphoid gate were sorted into IgM+, IgT+, or IgM− IgT− subsets
(SpL L IgM+, SpL L IgT+, and SpL L IgM− IgT−, respectively). IgM− IgT− cells outside the lymphocyte gate (SpL nL IgM− IgT) was also collected. Expression of
cd22 and cd79a genes were subsequently determined in the different splenocyte subpopulations (B). Each bar represents mean relative expression data from three
pooled samples (five fish per pooled sample) ± SEM. Means with different letters are significantly different (two-tailed t-test with Welch’s correction, p < 0.05). Due to
very low cell frequency, sorted IgT data was obtained from a pool of 15 fish.
400 µL SDS-PAGE Sample Buffer (62.5mM Tris-HCl pH 6.8, 1%
SDS, 10% glycerol) containing 50mM dithiothreitol (DTT) for
1 h at RT on an orbital rotator. The eluted proteins, representing
the cell surface proteins, were collected by column centrifugation
at 1,000× g for 2min.
For surface protein isolation in FACS-sorted IgM+ PBLs, cell
suspension was centrifuged at 500 × g for 5min at 4◦C, washed
twice with 3mL ice-cold PBS to remove residual FBS, and then
resuspended in 0.5mL ice-cold PBS prior to biotinylation (1 ×
106 IgM+ cells/mL biotin solution) as described above.
To maximize the quantity of surface proteins for subsequent
mass-spectrometry analysis, eluted proteins were concentrated
using the PierceTM Protein Concentrator PES 3K MWCO
(ThermoFisher Scientific) following the manufacturer’s protocol.
Mass Spectrometry Analyses
Surface proteins isolated from the ASK and SSP-9 cell lines,
naïve IgM+ PBLs, and control vs. LPS-stimulated IgM+ PBLs
were subjected to proteomics analyses. Concentrated surface
protein samples were directly lysed in 1× NuPAGE LDS sample
buffer (ThermoFisher Scientific), heated at 70◦C for 10min, and
then fractionated by SDS-PAGE for 5min at 200V followed by
Coomassie blue staining (SimplyBlue SafeStain; Thermo Fisher
Scientific). Protein bands were cut and subjected to in-gel trypsin
digestion before analysis by liquid chromatography-tandemmass
spectrometry (LC-MS/MS).
Gel slices were subjected to in-gel reduction, alkylation,
and protease digestion with 6 ng/µl trypsin (V5111; Promega)
(33). OMIX C18 tips (Varian, Inc., Palo Alto, CA, USA) were
used for sample cleanup and concentration. Peptide mixtures
containing 0.1% formic acid were loaded onto a Thermo Fisher
Scientific EASY-nLC 1,000 system and EASY-spray column
(C18; 2µm; 100 Å; 50µm; 50 cm). Peptides were fractionated
using a 2–100% acetonitrile gradient in 0.1% formic acid over
50min at a flow rate of 250 nl/min. The separated peptides
were analyzed using a ThermoFisher Scientific Q-Exactive mass
spectrometer.
Raw files from the QExactive were analyzed using the
Proteome Discoverer 2.2 software (Thermo Fisher). The
fragmentation spectra was searched against the NCBI non-
redundant (nr) Salmo salar 2017_1 database using an in-house
Mascot server (Matrix Sciences, UK). Peptide mass tolerances
used in the search were 10 ppm, and fragment mass tolerance
was 0.02 Da. Peptide ions were filtered using a false discovery rate
(FDR) set to 5 % for peptide identifications.
Relative protein quantitations were done using precursor ion
intensities in Proteome Discoverer 2.2. To determine the relative
protein amount in each sample, Exponentially Modified Protein
Abundance Index (emPAI) values were extracted from mascot
search results.
RNA Isolation and cDNA Synthesis
Total RNA from sorted cells was extracted using either the
RNeasy R© Mini (≥500,000 cells) or Micro (< 500,000 cells)
Kits (Qiagen), with in-column DNAse I treatment (Qiagen)
according to the manufacturer’s protocol. For sorted HKL, SpL,
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FIGURE 4 | Restrictive gene expression of candidate pan-B cell markers in peritoneal cavity leukocytes of salmon. Freshly isolated peritoneal leukocytes were sorted
based on size and granularity (FSC vs. SSC) and then surface expression of IgM or IgT. Representative dot plot of the PeL subpopulations are shown in (A) with mean
percentage of each fraction indicated in the graph. PeL subsets included IgM+ or IgT+ cells within the lymphoid gate (PeL L IgM + and PeL L IgT+, respectively) and
IgM− IgT− cells within the non-lymphoid gate (PeL nL IgM− IgT−). Expression of cd22 and cd79a genes were investigated in peritoneal leukocyte subpopulations
(B). Due to low cell frequency, PeL L IgM+ and PeL L IgT+ bars represent the relative expression data from pooled samples of 15 fish. Relative expression data for
PeL nL IgM− IgT− was obtained from the mean of 3 pooled samples (5 fish per pooled sample) ± SEM.
and PeL subsets, an extra centrifugation step at 5,000 × g for
10min was performed to remove the RNAProtect Cell Reagent
before proceeding to RNA extraction of the cell pellet. RNA
yield and purity were determined using Nanodrop ND-1,000
Spectrophotometer (Nanodrop Tec. Wilmington, DA, USA)
and stored at −80◦C. Isolated RNA (75–150 ng) was reverse
transcribed into cDNAs in 20 µl reaction volumes using the
QuantiTect Reverse Transription Kit (Qiagen) following the
manufacturer’s protocol. Resulting cDNA was diluted 1:5 and
stored at−20◦C until further use.
Gene Expression Analyses
Expression levels of RNA transcripts of selected genes were
analyzed by RT-qPCR on an ABI Prism 7500 FAST Cycler
(Applied Biosystems). cDNAs from sorted HKL subpopulations
(2.5 ng total cDNA input) was used per qPCR reaction (20 µL
final volume) using the Fast SYBR R© Green Master Mix (Applied
Biosystems). For SpL and PeL subsets, total cDNA input was
1.5 ng. Information for all primers used is listed in Table 1. The
efficiency of the amplification was determined for each primer
pair using serial 2-fold dilutions of pooled cDNA, and only
primer pairs with efficiencies between 1.90 and 2.10 were used.
Each sample was measured in duplicate under the following
conditions: 95◦C for 20 s followed by 40 cycles of 95◦C for 3 s
and 60◦C for 30 s.
The expression of individual genes was normalized to that of
Atlantic salmon elongation factor 1αβ (EF1αβ) and presented
as relative expression using the 2−1Ct method, where 1Ct is
determined by subtracting the EF-1α value from the target Ct
as described previously (35, 36). Negative controls with no
template were included in all experiments. A melting curve for
each PCR was determined by reading fluorescence every degree
between 60 and 95◦C to ensure only a single product had been
amplified.
Statistical analyses of RT-qPCR data were performed
in GraphPad Prism 5.04 using a two-tailed student t-test
with Welch’s correction when the F test indicated that the
variances of both groups differed significantly. The differences
between the mean values were considered significant when
p ≤ 0.05.
RESULTS
Our mass spectrometry approach was able to identify a
combined dataset of 3,140 proteins from our surface protein-
enriched salmon B cell and/or HK cell line samples (full list
of identified proteins is available at https://doi.org/10.18710/
JU3DWE), of which 21% were deemed to be membrane
proteins by GO-annotation or transmembrane predictions. This
percentage, however, may have been underestimated due to
incomplete annotation in some Atlantic salmon proteins. We
subsequently focused on surface protein orthologs that were
previously reported as part of the CD molecules in mice and/or
humans.
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TABLE 1 | Primers used for SYBR green qPCR assays.
Genes Accession no. Oligo name Sequence (5′-3′) Product size (bp) Efficiency
ef1αβ NM_001123629.1 Fwd CCCCTCCAGGACGTTTACAAA 57 1.97
Rev CACACGGCCCACAGGTACA
igd XM_014203123.1a Fwd CCAGGTCCGAGTGGGATCA 136 1.92
Rev TGGAGCAGGGTTGCTGTTG
mcsfr NM_001171807.1 Fwd CACCAGTAACCCTAACCACTTC 97 2.00
Rev GACCTGCTTGTCCTGCATTA
cd3-z2 NM_001123620.1 Fwd ATTCTGGATGGCTTCCTCCT 144 2.03
Rev TATTCGCCCATAACCACCTC
cd9 XM_014187224.1 Fwd GAGGCCTTGAAGGAGACATTAC 115 2.00
Rev CCTCCAGTCCTTCCTTCTTTG
cd22 XM_014165590.1 Fwd GCCAGAGGACAAAGGTCATTA 106 2.04
Rev CTGAGTGTATCTTGGAACATAGGAA
cd79a XM_014187908.1 Fwd TCTGAACGACTCAGGGTTGTA 105 2.02
Rev TTCACCATCGGCCTGTAGA
aUsed qPCR primers previously designed by Tadiso et al. (34).
CD Proteins Exclusively Identified From
Atlantic Salmon HK Cell Lines
A total of 38 and 39CD proteins were identified from ASK
and SSP-9 cells, respectively (Figure 1B). Nine CD proteins
were detected only in ASK cells, while 11CD proteins were
detected only in SSP-9 cells. Twenty-four CD proteins were
shared between these two cell lines.
CD Proteins Common to Atlantic Salmon B
Cells and HK Cell Lines
In agreement with the established broad expression of CD81
in mammals (37), this multifunctional tetraspanin protein was
detected in high quantities in all proteomics samples (Table 2).
Similarly, ubiquitously expressed transmembrane glycoproteins
(38–40), CD98 and CD147 were detected in salmon ASK, SSP-9,
and IgM+ peripheral B cells. CD147 can bind directly to CD98,
which associates with integrins, which is in turn involved in
cell adhesion, fusion, proliferation, and growth (41). CD98 was
more abundant in LPS-stimulated B cells than control (relative
abundance > 2.00; Table 2).
The tetraspanin CD63 and transmembrane protein CD156c,
also known to be expressed in many cell types (42, 43), were
identified in both ASK and B cells. CD63 functions as a transport
regulator implicated in intracellular protein trafficking (44). It
has been shown to down-regulate CD184 (CXCR4) by serving
as a molecular target of the transcriptional repressor Bcl6 (45).
CD156c (ADAM10) functions as a molecular scissor that cleaves
the extracellular regions of its transmembrane target proteins,
which is an important mechanism for the regulation of leukocyte
development and function (43).
The transmembrane protein receptor CD40 was detected
in both SSP-9 and IgM+ B cells. This member of the TNFR
superfamily has been initially characterized on B cells and
subsequently found to be expressed on antigen-presenting cells,
and many other immune and non-immune cells (46). The
binding of CD40 to its CD154 ligand (CD40L) regulates a
wide spectrum of cellular processes, including the activation,
proliferation, and differentiation of B cells (47). CD40 exhibited
the highest increase in salmon B cell surface expression upon
stimulation with a TI antigen, with relative abundance value of
8.60 in LPS-treated vs. control B cells (Table 2).
CD Proteins Exclusively Identified From
Atlantic Salmon B Cells
Out of the 21 total CD molecules Identified from salmon IgM+
PBLs, 15 were found to be present in these B cell samples only
and were not detected in the two salmon hematopoietic organ-
derived cell lines (Figure 1B). The receptor-like protein tyrosine
phosphatase, CD45, reported to be one of the most abundant cell
surface glycoproteins expressed on mammalian leukocytes (48),
was the most abundant protein detected in the salmon B cell
samples with a relative quantitation value of 1.79 as estimated
by emPAI (Table 2) based on protein coverage by the peptide
matches in the database search result (49).
B Cell-Restricted Proteins (CD22 and CD79A)
Two surface proteins (CD22 and CD79A) that previously
have been used as B cell-exclusive markers in mammals
were identified in the salmon B cell samples. CD22 is a
transmembrane glycoprotein that belongs to the sialic acid-
binding immunoglobulin-like lectins (SIGLEC) family that
serves as a BCR co-receptor (50, 51). In mammals, its expression
is predominantly exclusive to subsets of mature B cells, with
surface expression appearing simultaneously with surface IgD
and is subsequently lost on plasma cells (52–54). CD22 is a well-
established regulator of innate and adaptive B cell responses
in mammals [reviewed in (55)]. One of the main functions
of CD22 is to down-regulate the activation threshold of BCR
through its association with tyrosine phosphatases and other
signalingmolecules (51, 56). In addition to BCR signaling, several
initial studies in mice have shown that CD22 also regulates TLR
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signaling and the survival of B cells (55). However, it has been
suggested that CD22 likely functions differently between innate-
like B-1 and conventional B-2 cells since CD22 is differentially
regulated after BCR-mediated and -independent activation in
these B cell lineages (57).
CD79A, on the other hand, is an integral membrane protein
belonging to the Ig gene superfamily that associates with
membrane Ig on B cell surface and, together with CD79B, forms
the signal transduction region of the B cell antigen receptor
(BCR) complex (58, 59). Due to their importance in B cell
development and induction of B cell activation, CD79 proteins
are expressed in virtually all subsets of B cells (60), from the very
early stages of B cell development to plasma cells (61–65).
Tetraspanins (CD9 and CD53)
Of the four tetraspanin proteins that were identified by
proteomics, detectable quantities of CD9 and CD53 were only
present in salmon B cells, despite the reported surface expression
in different hematopoietic cell types (66, 67) and/or endothelial
cells (68) of their mammalian homologs. This protein family
consists of four-span transmembrane proteins that have been
described as “master organizers” of the plasma membrane
(69) and “molecular facilitators” (42) in a variety of biological
processes.
β2 Integrins (CD11a, CD11c, and CD18)
CD18 (ITGB2), CD11a (ITGAL), and CD11c (ITGAX) that were
detected on salmon B cell surface belong to the β2 integrin family
of adhesion and signaling molecules. Integrin β chain subunit
CD18 can pair with one of four alpha chain subunits (CD11a,
CD11b, CD11c, or CD11d) to form the CD11/CD18 complex
that play important roles in the recruitment of immune cells to
sites of inflammation, cell–cell contact formation, and regulation
of downstream effects on cellular signaling (70). In mammals,
these β2 integrin complexes are found exclusively on leukocytes,
particularly myeloid cells and NK cells, and to a lower expression
level, B and T lymphocytes.
Chemokine Receptors: CD184, CD185, and CDw199
Three chemokine receptors, CD184 (CXCR4), CD185 (CXCR5),
and CDw199 (CCR9) were identified in Atlantic salmon B cells.
These are G-protein coupled, seven-transmembrane receptors
with CD184 and CD185 classified into the C-X-C (alpha) class
and CDw199 into the CC (beta) class. CD184 and CD185 are
known to have broad expression acrossmany cell types, including
lymphocytes, endothelial, epithelial and hematopoietic stem cells
(71). Similarly, CDw199 is expressed in different leukocyte
subpopulations such as macrophages, dendritic cells, T cells, and
B cells (72–75). These chemokine receptors are important in the
migration, maturation, and function of B cells (76–78).
Other Surface Proteins (CD68, CD84-H1, CD87, and
CD282)
In addition to members of the protein families described above,
several other surface proteins were found present on salmon B
cells. These included CD68, CD84-H1, CD87, and CD282.
CD68, the human homolog of macrosialin, is a highly
glycosylated type I transmembrane protein belonging to the
lysosomal-associated membrane protein (LAMP) family of
glycoproteins (79). While this protein was initially regarded
as a macrophage marker (80), CD68 expression on other
hematopoietic and non-hematopoietic cell types have been
subsequently reported, including B cell lines (81–83).
CD84-H1 (a.k.a. CD2-F10 and SLAM9) belongs to the
signaling lymphocyte activation molecule (SLAM) family of cell
surface receptors within the immunoglobulin superfamily (84,
85). This protein has been shown to be widely expressed in many
immune cells of humans, including B cells (84, 85). However,
the exact function of CD84-H1 in B cells is still unclear. In
general, SLAM proteins are said to contribute to the generation
of long-term humoral immune response (86, 87).
CD87, also called urokinase plasminogen activator receptor
(uPAR), is a surface glycoprotein that mediates a wide range of
biological processes beyond plasminogen activation, including
cellular adhesion, migration, chemotaxis, and proliferation
[reviewed in (88, 89)]. In humans, CD87 is known to be
highly expressed on monocytes and granulocytes, particularly
on mature cells (90). As such, it is used as a surface marker
for terminal granulocytic maturation (91). Resting B and T
lymphocytes and cell lines of lymphoid lineage do not seem to
express CD87 (90, 92), although surface expression has been
reported on activated T cells and NK cells (90). Next to CD45 and
CD18, salmon CD87 had the highest emPAI obtained in naïve B
cells, with relative abundance comparable between control and
LPS-activated B cell samples.
Another surface protein detected on salmon B cell surface
was CD282, more commonly known as toll-like receptor
2 (TLR2), a membrane-bound protein that recognizes the
evolutionarily conserved bacterial lipopeptides (93). In humans,
surface expression of CD282 is found to be highest on innate
cells such as monocytes and granulocytes (94). Detectable level
of CD282 expression has also been observed on activated but not
resting T cells (95, 96), as well as on surface of different B cell
subpopulations, albeit mostly at low level (94, 97, 98).
B Cell-Restrictive Gene Expression of
Candidate Salmon Pan-B Cell Markers
Given the known B cell-exclusive surface expression of their
mammalian homologs, CD22 and CD79A were shortlisted as
potential pan-B cell markers for salmon. In the absence of
definitive Abs against these candidate markers, we resorted to
qPCR assays for validating their B cell restrictive expression using
leukocyte subsets from different lymphoid organs.
Sorted cells from HK (Figure 2A) were used as the main
source of different leukocyte subpopulations for the RT-qPCR
validation assays. As the major hematopoietic organ in teleost,
HK consists of a heterogeneous mixture of leukocytes belonging
to the lymphoid and myeloid lineages (99). HKL subsets were
first examined for gene expression of known markers for B cells,
macrophages, and T cells in order to confirm the nature of
cells present in each subset, as well as to ensure that no cross-
contamination of cell subsets occurred during FACS sorting.
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As expected, only the lymphoid subsets had detectable igd
expression, with transcript levels highest in the HK suspension
cell IgM+ lymphoid subset (HKL SC-L IgM+, Figure 2B), in
accordance with the reported dual IgM and IgD expression
in majority of naïve mature peripheral B cells of mammals
[reviewed in (100–102)] and trout (103). Significant albeit
much lower igd expression was also observed in HK suspension
cell IgM− lymphoid subset (HKL SC-L IgM−), which could
suggest the presence of IgD+ only B cells in naïve HKLs. By
contrast, the suspension and adherent IgM− non-lymphoid
subsets (HKL SC-nL IgM− and HKL AC-nL IgM−, respectively),
assumed to consist of myeloid cells (macrophages, monocytes,
and/or granulocytes), had very low to non-existent igd
expression.
The HK suspension cell IgM+ lymphoid subset had no
detectable transcription of the macrophage marker, mcsfr, which
was expressed in high levels in the putative myeloid cell subsets,
HKL SC-nL IgM− and HKL AC-nL IgM−. Detectable levels
of mcsfr transcripts was present in the HK suspension cell
IgM− lymphoid subset, which could indicate the presence of
contaminating macrophages in this leukocyte subpopulation.
Similarly, no detectable cd3-z2 gene expression was observed
in the HK suspension cell IgM+ lymphoid subset, while the
remaining HKL subsets exhibited relatively low expression of this
T cell marker.
Additionally, to ensure that any observed absence of
detectable transcripts was not due to poor cDNA/RNA quality
of our samples, the mRNA levels of the broadly expressed
CD9 tetraspanin were also determined in the sorted HKL
subpopulations. In general, relative expression of cd9 was
comparably high across all HKL subsets, with the HK suspension
cell IgM− non-lymphoid subset having the most expression.
The gene expression of our candidate B cell markers was
subsequently investigated. HK suspension cell IgM+ lymphoid
subset with a putative B cell phenotype (i.e., significant gene
expression of igd and cd9, but not mcsfr and cd3-z2) exhibited
the highest cd22 and cd79a expression (Figure 2C). By contrast,
very low to non-existent mRNA levels were observed in both
the suspension and adherent IgM− non-lymphoid subsets (HKL
SnL IgM− and HKL AnLIgM−, respectively), consisting mostly
of cells from the myeloid lineage and some T lymphocytes as
per mcsfr and cd3z gene expression profile. Low but detectable
levels of cd22 and cd79a were also observed in the HKL SL IgM−
subset, likely due to the presence of IgD+ and IgT+ B cells in this
leukocyte subpopulation.
To check whether the apparent B cell restrictive expression
of cd22 and cd79a is consistent across different B cells from
different lymphoid sources, we also performed the same gene
expression assay in leukocyte subsets from spleen (Figure 3A)
and peritoneal cavity (Figure 4A). IgT subpopulation was also
added in the analysis to determine cd22 and cd79a expression in
a non-IgM B cell isotype. Similar to what was observed in HKLs,
highest and lowest cd22 and cd79a mRNA levels were obtained
in the spleen IgM+ lymphoid (SpL L IgM+) and IgM− non-
lymphoid subsets (SpL nL IgM−), respectively (Figure 3B). High
mRNA expression for these candidate markers was also found in
the spleen IgT+ lymphoid subset (SpL L IgT+) as well as in the
IgM− IgT− lymphoid subset (SpL L IgM− IgT−), which could
contain IgD only B cells.
For PeLs, comparable levels of cd22 transcription were
observed between IgM+ (PeL L IgM+) and IgT+ (PeL L IgT+)
lymphoid subsets, while very low cd22 gene expression was
obtained in the PeL IgM− IgT− non-lymphoid subset (PeL nL
IgM− IgT−) (Figure 4B). Gene expression of cd79a, on the other
hand, was higher in the IgM+ than IgT+ peritoneal lymphoid
cells. Lowest cd79a expression was observed in the IgM− IgT−
non-lymphoid subset of the peritoneal leukocytes (PeL nL IgM−
IgT−).
DISCUSSION
To our knowledge, this is the first report on the profiling of
salmon B cell surface protein repertoire. Although proteomics
has been employed in some investigations of fish immune
responses to various infections [reviewed in (104)], it is not
commonly used to characterize the surface protein expression of
specific immune-related cells in teleosts. A previous proteomics
study on Atlantic salmon focused on profiling changes in fish
serum proteins following infection with salmonid alphavirus
(105). Our approach focused on B cells and was useful in
the identification of 21CD molecules from salmon IgM+ B
cells. The relatively limited number of CD proteins identified
could be partially explained by the initial low number of B
cells in the starting material (3 × 106 viable IgM+ B cells
after 72 h in culture) used in the surface protein isolation. In
addition, despite being one of the popular choices for cell surface
proteome profiling, the biotinylation technique employed for the
enrichment of plasma membrane proteins may not be the most
effective method for isolating glycosylated proteins (106). Since
majority of cell surface proteins are glycosylated (107), many
surface glycoproteins may not have been included in our mass
spectrometry samples.
Peripheral blood was used as source of salmon B cells for
proteomics due to higher total leukocyte yield [i.e., 15× and 4×
more total leukocytes than the spleen and the HK, respectively
(108)] and the abundance of IgM+ B cells in this compartment
(22). For comparison, surface proteins from two Atlantic salmon
head kidney cell lines, ASK and SSP-9, were also identified.
Although the exact cell composition of these hematopoietic-
tissue derived cell lines is unknown, these seem to include cells
from the myeloid lineage based on their respective proteomics
profile. Given its epithelial-like morphology and previously
reported gene expression profile (31), SSP-9 is likely comprised of
macrophage-like cells. Specifically, majority of the identified SSP-
9-exclusive surface proteins (CD2, CD34, CD74, CD151, CD205)
are associated with expression on a macrophage subset with
antigen-presenting capacity (109–113). Detection of CD203c, a
known basophil and mast cell marker in humans (114), suggest
that SSP-9 may contain granulocytes.
Salmon IgM+ B Cell Surface Proteome
All the surface proteins identified from our salmon B cell samples
have been previously detected on the surface of mammalian B
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cells, except for CD87. In teleost, only a few of these B cell-
associated proteins have been studied so far. Constitutive gene
expression of tetraspanins cd9 and cd63 have been reported in
sorted IgM+ B cells of trout from different immune organs (115).
Surface expression of CD22 has also been shown in PBLs of
tongue sole (116).
In keeping with their established roles in B cell activation,
CD40 (117) and CD98 (118) surface expression were significantly
higher in LPS-stimulated IgM+ B cell samples. Co-expression
of CD40 and IgM+ has been established on B cell surface
of zebrafish, with significant up-regulation of CD40 similarly
observed following LPS treatment (119). In addition, modest
increase in CD40 transcripts has been reported for Atlantic
salmon IgM+ B cells in the presence of another TLR agonist, CpG
oligodeoxynucleotides (22).
Surprisingly, CD87, which has been reported to be absent on
surface of resting B lymphocytes and B cell lines of mammals
(90, 92), was detected in our naïve salmon IgM+ B cell samples.
It should be noted that CD87 acts as a ligand for β2 integrins
such as CD18 and CD11a/c identified on salmon B cells, and thus
usually found in close association with these protein complexes
on leukocytes (120). CD87 has been demonstrated to mediate
cell-cell adhesion by interaction with integrins on the same as
well as apposing cells (121). Hence, the CD87 proteins detected
in our proteomics experiment may be an artifact from a CD87-β2
integrin complex formed by trans-interaction of salmon B cells
with CD87-expressing monocytes or granulocytes. It is unlikely
that the proteins were contributed directly by contaminating
monocytes or granulocytes since the samples were checked for
purity (>98% IgM+ PBLs) before surface protein isolation.
Alternatively, it is also possible that salmon, in contrast to
mammals, express CD87 on their B cell surface.
Peripheral blood provides the means for cells to move
systemically within the animal body; hence, one would expect
a mixture of circulating B cell subsets in this compartment.
Surface detection of chemokine receptors CXCR4, CXCR5, and
CCR9 important in trafficking naïve B lymphocytes (76) seem to
suggest that our peripheral IgM B cell population is comprised
of a migrating population of B cells from different lymphoid
compartments. In humans, the majority of peripheral B cells are
of the conventional B-2 cell type bearing both membrane IgM
and membrane IgD, which accounts for about 10% of total PBLs
(122). Given the current technical constraints, it was not possible
to further sort the largely undefined subsets of the salmon IgM+
peripheral B cell subpopulation.
More recently, it has been shown that, contrary to the dogma
that all plasma cells have permanently switched off expression
of membrane-bound Ig molecules to produce their secreted
version (antibodies), some mature plasma cells in mice retain
their expression of surface IgM and functional BCR (123, 124).
Thus, it is possible that our LPS-treated peripheral B cells
contained some differentiating IgM+ plasmablasts, plasma cells,
or memory B cells. However, none of the known markers for
these differentiated B cells [i.e., CD27 for memory B cells (125),
CD138 for plasma cells (126)] was identified in the stimulated
B cell samples. Based on previous studies in trout, this can
be partially explained by the relatively short stimulation period
(72 h incubation in culture) used in our study. In naïve trout
PBLs, significant antibody secreting cell response is observed only
after 4 days of LPS stimulation using 4 times higher dose, with
peak responses occurring by Day 7 in culture (127). In addition,
memory B cell responses to TI and TD antigens are observed only
after 4–7 days of in vitro re-stimulation of PBLs from previously
immunized trout (108).
It should be emphasized that several other mammalian
pan-B cell and subset markers known to be encoded in the
Atlantic salmon genome were not detected in our salmon
IgM+ B cell samples. Failure to detect a particular surface
protein should be interpreted with caution due to previously
indicated technical limitations of our experimental approach
or their presence at low frequency in our heterogeneous pool
of IgM+ B cell subpopulations. Moreover, it should be noted
that our shortlist of salmon CD proteins was based on their
mammalian counterparts. Other surface proteins that were
detected exclusively in the IgM+ samples but without homologs
or are not classified as CD molecules in mammals were not
included in this list. Further investigation of the “non-CD”
surface proteins is therefore needed in order to determine
whether or not these can serve as unique B cell markers in
salmon.
Identification of CD22 and CD79A as
Potential Salmon B Cell Markers
Due to lack of access to antibodies against salmon IgD
and myeloid markers, our analysis was constrained to
leukocyte subpopulations sorted by cell size and granularity
and subsequent positive selection for IgM+ or IgT+ cells,
representing independent salmon B cell lineages. Despite this
clear limitation, our current sorting protocol is still a valid useful
tool in studying the different salmon leukocyte populations as
evidenced by the results of our qPCR validation assays using
different leukocyte markers.
In general, cd22 vs. cd79a gene expression patterns of the
different leukocyte subsets were comparable across different
lymphoid organs. Highest relative expression were observed in
all IgM+ B cell subsets, while very low to below detectable
level of expression were found in IgM−/IgT− non-lymphoid
subset (likely consisting of myeloid cells). Relatively lower but
significant level of expression was also found in non-IgM subsets
within the lymphoid gate, which likely consist of either a mixed
population of IgT+ or IgD+ only B cells (i.e., HKL SC-L IgM−)
or IgD+ only B cells (i.e., SpL L IgM− IgT−). While generally
regarded as B cell-exclusive proteins (52, 128), it is important to
note that mammalian CD22 and CD79A have also been reported
to be expressed on the surface of some non-B cell populations,
including T cells (129) and various myeloid cells (130–133).
However, this is likely not the case for Atlantic salmon given
the negligible transcript levels of cd22 and cd79a in all the
myeloid-containing leukocyte subsets tested.
Although mRNA levels do not necessarily correlate directly
with surface protein expression, gene expression profiles of
salmon cd22 and cd79a clearly showed that the B cell exclusivity
of our candidate CD molecules extend down to the level of
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transcription. This B cell-restrictive expression was consistent
across different lymphoid compartments (peripheral blood, head
kidney, spleen, peritoneal cavity) and different Ig isotypes (IgM
and IgT), thus providing strong support to the potential of CD22
and CD79A as pan-B cell markers for salmon.
Extensive gene duplications in the Atlantic salmon genome
(134, 135) should be taken into account in finding appropriate
B cell markers. Specifically, Atlantic salmon encodes an
unusually high number of CD22-like paralogs and isoforms
(Supplementary Table 1) that could have different regulatory
expression and conformation on B cells. Interestingly, peptide
sequences specific to only one CD22 paralog was detected on
the salmon B cell surface in our mass spectrometry analysis.
Based on our qPCR assay, mRNA expression of this particular
variant was also specific in salmon B cells. In humans, a CD22
molecule with a different conformation to that found on B cells
has been detected on basophils (130). Whether other CD22
variants/isoforms are also expressed in other subpopulations of
salmon leukocytes, or in specific subsets of salmon B cells, is still
unknown, but is beyond the scope of this study. For simplicity,
the particular CD22 paralog (XP_014021065.1) identified in this
study was referred as CD22.
Other Potential B Cell Markers
CD45, the most abundant surface protein identified in our
salmon B cell samples, exists in different alternative splicing
isoforms, which are expressed in cell-type specific patterns on
functional subsets of mammalian lymphocytes (48). In mice,
a long isoform of CD45 called B220 (136) has been used as
a pan B-cell marker due to its specific expression throughout
stages of B cell development, including entry into the memory
B cell pool (137). A similar long CD45 isoform (CD45RABC) has
been identified in human B cells (96), which has been used as
marker for certain human B cell subsets (138). This B-cell specific
CD45 isoform in mammals consists of all 33 exons of the CD45
gene (139). Atlantic salmon genome encodes for seven CD45
transcript variants in Chromosome 10 (Supplementary Table 1),
with alternate splicing of three exons (4, 5, 6) producing six CD45
isoforms [GenBank Assembly Accession No. GCA_000233375.4
(135)]. Given that all exons are present in the B cell-specific
isoform, it was not possible to determine whether the long
CD45 isoform was the only isoform detected on salmon B cell
surface. Hence, further investigation for the presence of other
CD45 isoforms in sorted salmon B cell subpopulations (i.e., qPCR
assays using primers specific for the other splice variants) is still
needed before its potential as another salmon pan-B cell marker
can be fully appreciated.
Several other CD molecules identified on salmon B cell
samples can be explored for their potential in discriminating
specific B cell subsets despite their non-exclusive B cell surface
expression. Murine CD9 is expressed on the surface of innate-
like B cells and plasma cells, but not on naïve conventional B2
cells (140, 141). In our proteomics data, CD9 was detected in
high abundance in all samples of salmon IgM+ peripheral B cells
but not in either of the two salmon head kidney cell lines. This
implies that the salmon IgM+ peripheral B cell subpopulation
are comprised of cells with significantly high expression of this
protein. In rainbow trout, cd9 mRNA levels are similar in IgM+
and IgM− B cells from blood and HK (115). In agreement with
this, comparable levels of cd9 expression was also observed in
the IgM+ and IgM− fractions of our sorted HKL lymphoid
cells, but highest constitutive gene expression was still found in
the myeloid fractions. Thus, while CD9 cannot be used as the
sole and primary marker for salmon B cells, its potential for
identifying specific B cell subsets should be explored further.
Other potential B cell subset markers are the CD11 β2
integrins. In contrast to mammals wherein four β2 integrins
have been identified, Atlantic salmon genome encodes only two:
CD11a and CD11c. Both of these proteins were detected in
our salmon IgM+ B cell samples, which could suggest their
potential use as markers to functionally-equivalent B cell subsets
in mammals. High surface CD11a expression has been associated
with a new subpopulation of IFN-γ-secreting innate B cells (142).
Expression of CD11c has also been recently used as marker for
distinct B cell subsets in mice and humans (143, 144), including
CD11clow-expressing plasmablasts that predominantly secrete
Ag-specific IgM antibodies in a T cell-independent manner (145)
and CD11c+ ‘atypical memory B cells’ (144).
Interestingly, CD11b, which is used as amarker to differentiate
B1 cells that reside in the peritoneal cavity and those that
recently migrated into the spleen (146), has not been detected
until present. Among salmonids, only coho and Chinook
salmon have CD11b-like protein recorded in the sequence
database. However, the salmonid sequences of CD11c (ITGAX)
is very similar to that of CD11b (70). In fact, Atlantic salmon
CD11c (XP_014014772.1) has 70 and 90% homology with
CD11c-like proteins of coho (XP_020308950.1) and Chinook
(XP_024269535.1) salmon, respectively. Similarly, CD11d, which
is only found in coho (XP_020334852.1), has 95% homology with
Atlantic salmon CD11a (XP_014032228.1). At this point, it is
unknown whether Atlantic salmon CD11c-like and CD11a-like
proteins have overlapping functions with the mammalian CD11b
and CD11d proteins, and whether expression patterns of these
mammalian B cell subset markers are similar to their ancestral
counterpart in teleosts.
Salmon IgM+ B Cell Surface Phenotype Is
Consistent With Innate-Like B Cells of
Mammals
It is worthy to note that several of the surface proteins (CD9,
CD11a, CD11c) identified on salmon IgM+ B cells in high
abundance are associated with innate-like B cells in mice and
humans. CD22, one of the identified potential salmon B cell
marker in this study, is also known to be expressed the highest
in MZ B cell precursors out of any mammalian B cell subset
(147). Additionally, detection of CD282 (TLR2), which has been
previously shown to be expressed higher in naïve innate-like B
cells than conventional B2 cells (97), implies a possible function
of salmon IgM+ peripheral B cells in TI-responses. Altogether,
these are consistent with a salmon IgM+ B cell phenotype closer
to innate-like B cells (B1 and MZ B2) than conventional B2
cells in mammals. This supports the previously proposed B cell
evolution hypothesis (18) which suggests that teleost IgM B cells
are the ancestors of the innate-like B cells of mammals (25, 148).
Whether these innate-like B cell-associated proteins detected
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from our B cell samples are evenly expressed on the surface of
all salmon IgM+ B cells or only expressed at very high levels
on certain sub-populations, is a question that warrants further
investigations. This can be determined upon availability of the
necessary immunological tools and antibodies to analyze the
frequency and level of their surface expression.
Speculations regarding the possible characteristics of salmon
IgM B cell populations based solely on pre-conceived notions
of the surface phenotype, function, and anatomical distribution
of their mammalian counterparts should come with a caveat.
Indeed, the conservation of protein functions between mammals
and teleosts for many of the B cell-associated CD molecules
identified in this study has to be established. Therefore, subsets
comprising the salmon IgM+ B cells need to be better defined,
in order to facilitate further functional studies of these individual
surface proteins.
SUMMARY AND CONCLUSION
In summary, our salmon B cell proteomics approach provide
novel information on the surface phenotype of salmon IgM
B cells as well as some evolutionary insights in reference to
their mammalian counterparts. While possible exclusion of
several glycosylated and/or less abundant proteins cannot be
discounted due to technical limitations of the protocols used, our
detection of 21CD molecules remains a significant advancement
in profiling the salmon B cell surface proteome. In addition,
identification of CD22 and CD79A as potential pan-B cell
markers represents a considerable positive step toward salmon B
cell marker development. Further investigation and evaluation of
the salmon CD molecules identified in this study would improve
our understanding of B cell dynamics in salmon in the presence
of TI and TD antigens during immunostimulation, pathogen
infection, or vaccination.
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